Cargando…
Lipocalin 2: a potential therapeutic target for breast cancer metastasis
Although systematic therapeutic approaches have reduced cancer-associated mortality, metastatic breast cancer can still evade therapy, particularly triple-negative breast cancer, which remains associated with high rates of cancer metastasis and has the worst clinical prognosis. Lipocalin 2 (LCN2) is...
Autores principales: | Hu, Chenxia, Yang, Ke, Li, Mengjie, Huang, Weiping, Zhang, Fengxue, Wang, Hongqi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6239117/ https://www.ncbi.nlm.nih.gov/pubmed/30519052 http://dx.doi.org/10.2147/OTT.S181223 |
Ejemplares similares
-
Hippo/TEAD4 signaling pathway as a potential target for the treatment of breast cancer
por: Wu, Yujian, et al.
Publicado: (2021) -
Lipocalin 2 promotes lung metastasis of murine breast cancer cells
por: Shi, Han, et al.
Publicado: (2008) -
Biological Functions and Therapeutic Potential of Lipocalin 2 in Cancer
por: Santiago-Sánchez, Ginette S., et al.
Publicado: (2020) -
miR-330-5p inhibits H(2)O(2)-induced adipogenic differentiation of MSCs by regulating RXRγ
por: Huang, Weiping, et al.
Publicado: (2018) -
Curcumin and Glu-GNPs Induce Radiosensitivity against Breast Cancer Stem-Like Cells
por: Yang, Ke, et al.
Publicado: (2020)